Glenmark

Glenmark Launches World’s First Nebulized Triple Therapy for COPD, Setting a New Benchmark in Respiratory Care

Glenmark Launches World’s First Nebulized Triple Therapy for COPD, Setting a New Benchmark in Respiratory Care

6 hours ago

1 min read

Glenmark Specialty Partners with Hengrui Pharma to Develop Next-Generation HER2 ADC Trastuzumab Rezetecan

Precision Medicine

Glenmark Specialty Partners with Hengrui Pharma to Develop Next-Generation HER2 ADC Trastuzumab Rezetecan

Curated By - Dr Manisha Khurana

24 Sep 2025

2 min read

Glenmark’s Subsidiary Inks $700 Million Global Licensing Deal with AbbVie for Novel Cancer Therapy ISB 2001

Glenmark’s Subsidiary Inks $700 Million Global Licensing Deal with AbbVie for Novel Cancer Therapy ISB 2001

11 Jul 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com